Abstract
The purpose of preoperative evaluation is to optimize the patient’s status before surgery and thereby minimize risk. Generally the most feared post-operative cardiac complications are myocardial infarction, heart failure, malignant arrhythmias, and death. Factors to consider during the preoperative evaluation are patient risk factors, patient functional capacity, and the type of surgery the patient will undergo. Patients with comorbidities such as peripheral arterial disease have higher incidences of underlying coronary artery disease and left ventricular dysfunction. Deconditioned patients also have a higher incidence of cardiac complications. Finally, certain procedures, such as vascular surgery or major thoracic and abdominal procedures, predispose to myocardial ischemia due to greater blood loss, fluid shifts, increased myocardial oxygen demand (due to increased heart rate and blood pressure), and increased post-operative platelet reactivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee TH et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043.
Fleisher LA et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:e13.
Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333:1750.
McFalls EO et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795.
Leon MB et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665.
Lindenauer PK et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349.
Dunkelgrun M et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg. 2009;249:921–6.
Winchester DE et al. Evidence of pre-procedural statin therapy: a meta-analysis of randomized trials. J Am Coll Cardiol. 2010;56:1099–109.
POISE Study Group, Devereaux PJ, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371:1839.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London Limited
About this chapter
Cite this chapter
Reuter, J.E., Teeters, J.C. (2012). Preoperative Cardiovascular Risk Assessment for Non-cardiac Surgery. In: Bisognano, J., Beck, R., Connell, R. (eds) Manual of Outpatient Cardiology. Springer, London. https://doi.org/10.1007/978-0-85729-944-4_18
Download citation
DOI: https://doi.org/10.1007/978-0-85729-944-4_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-943-7
Online ISBN: 978-0-85729-944-4
eBook Packages: MedicineMedicine (R0)